Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

1-25 of 47 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2

Diverse Mechanisms of Protective Anti-Pneumococcal Antibodies.
Gingerich AD, Mousa JJ
Front Cell Infect Microbiol, 12:824788, 28 Jan 2022
Cited by: 10 articles | PMID: 35155281 | PMCID: PMC8834882
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The impact and cost-effectiveness of introducing the 10-valent pneumococcal conjugate vaccine into the paediatric immunisation programme in Iceland-A population-based time series analysis.
Eythorsson E, Ásgeirsdóttir TL, Erlendsdóttir H, Hrafnkelsson B, Kristinsson KG, Haraldsson Á
PLoS One, 16(4):e0249497, 08 Apr 2021
Cited by: 3 articles | PMID: 33831049 | PMCID: PMC8031404
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Review on Pneumococcal Infection in Children.
Thadchanamoorthy V, Dayasiri K
Cureus, 13(5):e14913, 09 May 2021
Cited by: 9 articles | PMID: 34123613 | PMCID: PMC8189266
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial.
Leach AJ, Mulholland EK, Santosham M, Torzillo PJ, McIntyre P, Smith-Vaughan H, Wilson N, Arrowsmith B, Beissbarth J, Chatfield MD, Oguoma VM, Licciardi P, Skull S, Andrews R, Carapetis J, McDonnell J, Krause V, Morris PS
Vaccine X, 7:100086, 15 Feb 2021
Cited by: 7 articles | PMID: 33681756 | PMCID: PMC7930582
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Serotype and molecular diversity of nasopharyngeal Streptococcus pneumoniae isolates from children before and after vaccination with the ten-valent pneumococcal conjugate vaccine (PCV10) in Ethiopia.
Sime WT, Aseffa A, Woldeamanuel Y, Brovall S, Morfeldt E, Henriques-Normark B
BMC Infect Dis, 19(1):409, 10 May 2019
Cited by: 8 articles | PMID: 31077141 | PMCID: PMC6511162
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Relationship between immune response to pneumococcal conjugate vaccines in infants and indirect protection after vaccine implementation.
Dagan R
Expert Rev Vaccines, 18(6):641-661, 22 Jun 2019
Cited by: 16 articles | PMID: 31230486
Add to export list Review
Effectiveness and impact of the 10-valent pneumococcal conjugate vaccine, PHiD-CV: review of clinical trials and post-marketing experience.
Mrkvan T, Pelton SI, Ruiz-Guiñazú J, Palmu AA, Borys D
Expert Rev Vaccines, 17(9):797-818, 01 Sep 2018
Cited by: 9 articles | PMID: 30185083
Add to export list Review
Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumococcal carriage in Fiji: results from four annual cross-sectional carriage surveys.
Dunne EM, Satzke C, Ratu FT, Neal EFG, Boelsen LK, Matanitobua S, Pell CL, Nation ML, Ortika BD, Reyburn R, Jenkins K, Nguyen C, Gould K, Hinds J, Tikoduadua L, Kado J, Rafai E, Kama M, Mulholland EK, Russell FM
Lancet Glob Health, 6(12):e1375-e1385, 01 Dec 2018
Cited by: 32 articles | PMID: 30420033 | PMCID: PMC6231327
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Pneumococcal Vaccines: Host Interactions, Population Dynamics, and Design Principles.
Croucher NJ, Løchen A, Bentley SD
Annu Rev Microbiol, 72:521-549, 01 Sep 2018
Cited by: 27 articles | PMID: 30200849
Add to export list
Rationale and methods of a randomized controlled trial of immunogenicity, safety and impact on carriage of pneumococcal conjugate and polysaccharide vaccines in infants in Papua New Guinea.
Lehmann D, Kirarock W, van den Biggelaar AHJ, Passey M, Jacoby P, Saleu G, Masiria G, Nivio B, Greenhill A, Orami T, Francis J, Ford R, Kirkham LA, Solomon V, Richmond PC, Pomat WS, 10v13v PCV trial team
Pneumonia (Nathan), 9:20, 25 Dec 2017
Cited by: 5 articles | PMID: 29299402 | PMCID: PMC5742486
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Direct and Indirect Effectiveness of the 10-Valent Pneumococcal Conjugate Vaccine Against Carriage in a Cluster Randomized Trial.
Palmu AA, Toropainen M, Kaijalainen T, Siira L, Lahdenkari M, Nieminen H, Syrjänen RK, Kilpi TM, Jokinen J
Pediatr Infect Dis J, 36(12):1193-1200, 01 Dec 2017
Cited by: 8 articles | PMID: 28737627
Add to export list
Impact of protein D-containing pneumococcal conjugate vaccines on non-typeable Haemophilus influenzae acute otitis media and carriage.
Clarke C, Bakaletz LO, Ruiz-Guiñazú J, Borys D, Mrkvan T
Expert Rev Vaccines, 16(7):1-14, 07 Jun 2017
Cited by: 24 articles | PMID: 28571504
Add to export list Review
Cost-effectiveness analysis of a universal mass vaccination program with a PHiD-CV 2+1 schedule in Malaysia.
Wang XJ, Saha A, Zhang XH
Cost Eff Resour Alloc, 15:17, 22 Aug 2017
Cited by: 8 articles | PMID: 28852326 | PMCID: PMC5568314
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae among children in São Paulo, Brazil.
Brandileone MC, Zanella RC, Almeida SCG, Brandao AP, Ribeiro AF, Carvalhanas TMP, Sato H, Andrade AL, Verani JR, Pneumococcal Carriage Study Group
Vaccine, 34(46):5604-5611, 28 Sep 2016
Cited by: 50 articles | PMID: 27692770
Add to export list
Polysaccharide conjugate vaccine protein carriers as a "neglected valency" - Potential and limitations.
Bröker M, Berti F, Schneider J, Vojtek I
Vaccine, 35(25):3286-3294, 06 May 2017
Cited by: 34 articles | PMID: 28487056
Add to export list Review
Cost-effectiveness analysis of infant universal routine pneumococcal vaccination in Malaysia and Hong Kong.
Wu DB, Roberts C, Lee VW, Hong LW, Tan KK, Mak V, Lee KK
Hum Vaccin Immunother, 12(2):403-416, 01 Jan 2016
Cited by: 21 articles | PMID: 26451658 | PMCID: PMC5049716
Add to export list Free full text in Europe PMC
Haemophilus haemolyticus Interaction with Host Cells Is Different to Nontypeable Haemophilus influenzae and Prevents NTHi Association with Epithelial Cells.
Pickering JL, Prosser A, Corscadden KJ, de Gier C, Richmond PC, Zhang G, Thornton RB, Kirkham LA
Front Cell Infect Microbiol, 6:50, 09 May 2016
Cited by: 19 articles | PMID: 27242968 | PMCID: PMC4860508
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine.
Leach AJ, Wigger C, Hare K, Hampton V, Beissbarth J, Andrews R, Chatfield M, Smith-Vaughan H, Morris PS
BMC Pediatr, 15:162, 19 Oct 2015
Cited by: 38 articles | PMID: 26482232 | PMCID: PMC4615539
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The Efficacy and Duration of Protection of Pneumococcal Conjugate Vaccines Against Nasopharyngeal Carriage: A Meta-regression Model.
Le Polain De Waroux O, Flasche S, Prieto-Merino D, Goldblatt D, Edmunds WJ
Pediatr Infect Dis J, 34(8):858-864, 01 Aug 2015
Cited by: 20 articles | PMID: 26075814
Add to export list
Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media-A Double-Blind Randomized Clinical Trial in Finland.
Vesikari T, Forsten A, Seppä I, Kaijalainen T, Puumalainen T, Soininen A, Traskine M, Lommel P, Schoonbroodt S, Hezareh M, Moreira M, Borys D, Schuerman L
J Pediatric Infect Dis Soc, 5(3):237-248, 28 Apr 2016
Cited by: 43 articles | PMID: 27125273 | PMCID: PMC5125453
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Changes in pneumococcal nasopharyngeal colonization among children with respiratory tract infections before and after use of the two new extended-valency pneumococcal conjugated vaccines.
Ahn JG, Choi SY, Kim DS, Kim KH
Infect Dis (Lond), 47(6):385-392, 24 Feb 2015
Cited by: 8 articles | PMID: 25712791
Add to export list
Predicting the impact of new pneumococcal conjugate vaccines: serotype composition is not enough.
Hausdorff WP, Hoet B, Adegbola RA
Expert Rev Vaccines, 14(3):413-428, 30 Sep 2014
Cited by: 32 articles | PMID: 25266168
Add to export list Review
Trends in the epidemiology of invasive Haemophilus influenzae disease in Queensland, Australia from 2000 to 2013: what is the impact of an increase in invasive non-typable H. influenzae (NTHi)?
Wan Sai Cheong J, Smith H, Heney C, Robson J, Schlebusch S, Fu J, Nourse C
Epidemiol Infect, 143(14):2993-3000, 12 Mar 2015
Cited by: 16 articles | PMID: 25762194 | PMCID: PMC9151033
Add to export list Free full text in Europe PMC
10-Valent pneumococcal non-typeable haemophilus influenzae protein D-conjugate vaccine: a review in infants and children.
Plosker GL
Paediatr Drugs, 16(5):425-444, 01 Oct 2014
Cited by: 20 articles | PMID: 25192686
Add to export list Review
The effect of prophylactic antipyretic administration on post-vaccination adverse reactions and antibody response in children: a systematic review.
Das RR, Panigrahi I, Naik SS
PLoS One, 9(9):e106629, 02 Sep 2014
Cited by: 30 articles | PMID: 25180516 | PMCID: PMC4152293
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 47 results

1 2

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

Diverse Mechanisms of Protective Anti-Pneumococcal Antibodies.

The impact and cost-effectiveness of introducing the 10-valent pneumococcal conjugate vaccine into the paediatric immunisation programme in Iceland-A population-based time series analysis.

Review on Pneumococcal Infection in Children.

Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial.

Serotype and molecular diversity of nasopharyngeal Streptococcus pneumoniae isolates from children before and after vaccination with the ten-valent pneumococcal conjugate vaccine (PCV10) in Ethiopia.

Relationship between immune response to pneumococcal conjugate vaccines in infants and indirect protection after vaccine implementation.

Effectiveness and impact of the 10-valent pneumococcal conjugate vaccine, PHiD-CV: review of clinical trials and post-marketing experience.

Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumococcal carriage in Fiji: results from four annual cross-sectional carriage surveys.

Pneumococcal Vaccines: Host Interactions, Population Dynamics, and Design Principles.

Rationale and methods of a randomized controlled trial of immunogenicity, safety and impact on carriage of pneumococcal conjugate and polysaccharide vaccines in infants in Papua New Guinea.

Direct and Indirect Effectiveness of the 10-Valent Pneumococcal Conjugate Vaccine Against Carriage in a Cluster Randomized Trial.

Impact of protein D-containing pneumococcal conjugate vaccines on non-typeable Haemophilus influenzae acute otitis media and carriage.

Cost-effectiveness analysis of a universal mass vaccination program with a PHiD-CV 2+1 schedule in Malaysia.

Effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae among children in São Paulo, Brazil.

Polysaccharide conjugate vaccine protein carriers as a "neglected valency" - Potential and limitations.

Cost-effectiveness analysis of infant universal routine pneumococcal vaccination in Malaysia and Hong Kong.

Haemophilus haemolyticus Interaction with Host Cells Is Different to Nontypeable Haemophilus influenzae and Prevents NTHi Association with Epithelial Cells.

Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine.

The Efficacy and Duration of Protection of Pneumococcal Conjugate Vaccines Against Nasopharyngeal Carriage: A Meta-regression Model.

Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media-A Double-Blind Randomized Clinical Trial in Finland.

Changes in pneumococcal nasopharyngeal colonization among children with respiratory tract infections before and after use of the two new extended-valency pneumococcal conjugated vaccines.

Predicting the impact of new pneumococcal conjugate vaccines: serotype composition is not enough.

Trends in the epidemiology of invasive Haemophilus influenzae disease in Queensland, Australia from 2000 to 2013: what is the impact of an increase in invasive non-typable H. influenzae (NTHi)?

10-Valent pneumococcal non-typeable haemophilus influenzae protein D-conjugate vaccine: a review in infants and children.

The effect of prophylactic antipyretic administration on post-vaccination adverse reactions and antibody response in children: a systematic review.

Partnerships & funding